Implantable contraceptive devices: Primum non nocere

Journal of Family Planning and Reproductive Health Care

Volumn 32, Issue 3, 2006, Pages 190-192

  Bragg, Thomas W H ^a   Jose, Rajive M ^a   Bland, John W ^a   Matthews, Richard N ^a   Srivastava, Shekhar ^a  

^a GEORGE ELIOT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL;

ADULT; ARTICLE; CASE REPORT; CONTRACEPTIVE DEVICE; CONTUSION; CONVALESCENCE; DEVICE REMOVAL; FAMILY PLANNING; FEMALE; HAND PARESTHESIA; HUMAN; IMPLANTABLE PORT SYSTEM; LOCAL ANESTHESIA; MUSCLE WEAKNESS; NEUROPATHY; PHYSIOTHERAPY; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; SPLINTING;

ADULT; CONTRACEPTIVE DEVICES, FEMALE; DEVICE REMOVAL; DRUG IMPLANTS; FEMALE; HUMANS;

EID: 33746293894     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118906777888503     Document Type: Article

References (18)

1. Shulman LP, Nelson AL, Darney PD. Recent developments in hormone delivery systems. Am J Obstet Gynecol 2004: 190 (Suppl. 4): S39-S48.
2. Harrison-Woolrych M, Hill R. Unintended pregnancies with the etonogestrel implant (Implanon): a case series from post marketing experience in Australia. Contraception 2005; 71: 306-308.
3. Agrawal A, Robinson C. An assessment of the first 3 years' use of Implanon in Luton. J Fam Plann Reprod Health Care 2005; 31: 310-312.
4. Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, Schmidt J, et al; The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 2005; 71: 319-326.
5. Hatcher RA, Schnare S. Ask the experts: progestogen-only contraceptives. Contracept Technol Update 1993; 14: 114-115.
6. Organon Laboratories Ltd. Summary of Product Characteristics; Implanon Implant. RA0450 UK S5 (Ref 6.0).
7. British National Formulary, Vol. 50. Parenteral progestogen-only contraceptives; Implanon (Section 7.3.2.2; p. 414). September 2005. http://bnf.org [Accessed 7 February 2006].
8. Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E. Insertion problems, removal problems, and contraception failures with Implanon. Gynecol Obstet Fertil 2005; 33: 986-990.
9. Sarma, SP, Hatcher RP. Neurovascular injury during removal of levonorgestrel implants. Am J Obstet Gynecol 1995; 172: 120-121.
10. Praptohardjo U, Wibowo S. The 'U' technique: a new method for Norplant implants removal. Contraception 1993; 48: 526-536.
11. Mascarenhas L. Insertion and removal of Implanon: practical considerations. Eur J Contracept ReprodHealth Care 2000; 5 (Suppl. 2): 29-34.
12. Walling M. How to remove impalpable Implanon® implants. J Fam Plann Reprod Health Care 2005; 31: 320-321.
13. Piessens SG, Palmer DC, Sampson AJ. Ultrasound localisation of non-palpable Implanon. Aust N Z J Obstet Gynaecol 2005; 45: 112-116.
14. Letterie GS, Garnaas M. Localization of "lost" Norplant capsules using compression film screen mammography. Obstet Gynecol 1995; 85(5 Pt 2, Suppl.): 886-887.
15. Evans R, Holman R, Lindsay E. Migration of Implanon®: two case reports. J Fam Plann Reprod Health Care 2005; 31: 71-72.
16. Silverstein MI, Lewis CA, Sheline ME, Sarma SP. Fluoroscopically guided Norplant removal. J Vasc Interv Radiol 2001; 12: 253-255.
17. Merki-Feld GS. Nonpalpable ultrasonographically not detectable Implanon rods can be localised by MRI. Contraception 2001; 63: 325-328.
18. Stillwell S, Shepperd P, Searle S. The impalpable Implanon®: a case report. J Fam Plann Reprod Health Care 2003; 29(3): 156-157.